Sort
16,300 grants matching “fatty liver disease”
The novel adipokine, CTRP3, as an inhibitor of Alcoholic Fatty Liver Disease
$73,000Jonathan M Peterson · East Tennessee State University · R03 · FY2016 · AA
The novel adipokine, CTRP3, as an inhibitor of Alcoholic Fatty Liver Disease
$73,000Jonathan M Peterson · East Tennessee State University · R03 · FY2015 · AA
Wearable sensor for passive detection and efficient treatment of multiple disorders
$72,873Erica Silvia Forzani · Arizona State University-Tempe Campus · R03 · FY2019 · EB
NEUROENDOCRINE RESPONSE TO GASTRIC BYPASS IN NONHUMAN PRIMATES
$72,831Kevin L Grove · Oregon Health & Science University · P51 · FY2011 · RR
Synthesis, quantification and in vivo assessment of arsenolipids prevalent in seafoods
$72,810Amrika Deonarine · Texas Tech University · R03 · FY2022 · ES
Endothelial Signaling in Exercise Metabolism
$72,753Siobhan M Craige · Virginia Polytechnic Inst And St Univ · R03 · FY2024 · AR
Pilot Trial UO1 DUR-928
$72,752Craig J McClain · University Of Louisville · U01 · FY2019 · AA
The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
$72,706Laura Elisabeth Dichtel · Massachusetts General Hospital · K23 · FY2021 · DK
Impact of the P479L Variant in CPT1A on Infant Mortality in Alaska
$72,615David M Koeller · Oregon Health & Science University · R03 · FY2011 · HD
Role of necroptosis in inflammation and NAFLD to HCC progression
$72,500Deepa Sathyaseelan · University Of Oklahoma Hlth Sciences Ctr · R03 · FY2022 · CA
Role of necroptosis in inflammation and NAFLD to HCC progression
$72,500Deepa Sathyaseelan · University Of Oklahoma Hlth Sciences Ctr · R03 · FY2023 · CA
Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis
$72,480Cynthia A Moylan · Duke University · U01 · FY2024 · DK
Wearable sensor for passive detection and efficient treatment of multiple disorders
$72,423Erica Silvia Forzani · Arizona State University-Tempe Campus · R03 · FY2021 · EB
Relationship of metabolic abnormalities to hepatic steatosis in HIV
$72,290Richard K. Sterling · Virginia Commonwealth University · R03 · FY2008 · DK
NITROGEN HETEROCYCLES: METABOLIC EFFECTS AND TOXICITY
$72,265Wayne State University · R01 · FY2000 · ES
Infant Temperament &Feeding: Predictors of Weight Gain
$72,236Rutgers The St Univ Of Nj New Brunswick · R03 · FY2002 · HD
Apolipoprotein CIII inhibition in partial lipodystrophy
$72,218Rebecca Brown · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Biospecimen & Biomarker Development Core
$72,123Michael E. Scheurer · Baylor College Of Medicine · P01 · FY2022 · CA
CONTROL OF GENE TRANSCRIPTION BY ESSENTIAL FATTY ACIDS
$72,117University Of Texas Austin · R01 · FY2002 · DK
INVESTIGATOR INITIATED STUDY OF THE EFFECTS OF ANDROGEN THERAPY ON CARBOHYDRA
$71,889Fred R Sattler · University Of Southern California · M01 · FY2009 · RR
Resource for Rat Genetic Models of Aerobic Capacity
$71,885Lauren Gerard Koch · University Of Michigan At Ann Arbor · P40 · FY2017 · OD
CTRP and Metabolic Control
$71,857Guang William Wong · Johns Hopkins University · R01 · FY2017 · DK
Lifecourse dietary exposures and offspring hepatic fat in early childhood: a nutrigenomic approach
$71,814Catherine Cioffi Cohen · University Of Colorado Denver · F32 · FY2022 · DK
Associations between Gut Microbiota, Plasma Metabolites, and Metabolic Syndrome Traits
$71,792Sahereh Mirzaei · University Of California Los Angeles · F32 · FY2023 · NR
Elucidating novel molecular mechanisms of irisin-mediated effects via integrin
$71,792Mu A · Dana-Farber Cancer Inst · F32 · FY2023 · DK